Elevai Labs, Inc.
ELABPMGC Holdings Inc. is a diversified holding company that acquires and operates businesses across the biotechnology, advanced manufacturing, specialty packaging, and investment sectors.
Table of contents
Earnings
Next report
Date not yet announcedCompetitors
By market cap
Profile
PMGC Holdings Inc. is a diversified holding company that acquires and operates businesses across the biotechnology, advanced manufacturing, specialty packaging, and investment sectors. The company focuses on identifying scalable opportunities with strong fundamentals, currently managing a portfolio that ranges from clinical-stage metabolic therapeutics to high-precision industrial components.
The company positions itself as a diversified operator with niche leadership in oral myostatin formulations for muscle preservation and high-precision manufacturing for aerospace and IT hardware.
Questions, answered.
- What is Elevai Labs, Inc.'s market cap?
- Elevai Labs, Inc. (ELAB) has a market capitalization of $5.0M and trades on NASDAQ.
- Who are Elevai Labs, Inc.'s competitors?
- Elevai Labs, Inc.'s key competitors include Eli Lilly, Amgen, Regeneron Pharmaceuticals, and others. These companies compete in similar markets and product categories.
- Who does Elevai Labs, Inc. partner with?
- Elevai Labs, Inc.'s notable partners include Goldman Sachs.
- What subsidiaries does Elevai Labs, Inc. have?
- Elevai Labs, Inc.'s subsidiaries include Northstrive Biosciences Inc., PMGC Capital LLC, Pacific Sun Packaging, Inc., and others.
- Where is Elevai Labs, Inc. headquartered?
- Elevai Labs, Inc. is headquartered in United States of America and employs approximately 18 people. It has been publicly traded since 2023.